ScholarIQanswers from OpenAlex & ORCID
Claudio Viscoli
ResearcherPublications, citations & collaboration network
Claudio Viscoli is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Claudio Viscoli have?
ScholarIQindexed works
Claudio Viscoli has 516 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Claudio Viscoli have?
ScholarIQcitation count
Claudio Viscoli has 37,322 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Claudio Viscoli?
ScholarIQh-index
Claudio Viscoli has an h-index of 85 in OpenAlex.
What is the i10-index of Claudio Viscoli?
ScholarIQi10-index
Claudio Viscoli has an i10-index of 301 in OpenAlex.
What is the OpenAlex record for Claudio Viscoli?
ScholarIQopenalex
The OpenAlex for Claudio Viscoli is on the source record.
What are the most-cited papers on Claudio Viscoli?
ScholarIQmost cited works
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello, Pierluigi Viale, Claudio Viscoli, Enrico Maria Trecarichi, Fabio Tumietto, Anna Marchese, Teresa Spanu, Simone Ambretti, Francesca Ginocchio, Francesco Cristini, Angela Raffaella Losito, Sara Tedeschi, Roberto Cauda, Matteo Bassetti
Infections caused by KPC-producing <i>Klebsiella pneumoniae</i> : differences in therapy and mortality in a multicentre study
Mario Tumbarello, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa, Maddalena Giannella, Daniele Roberto Giacobbe, Matteo Bassetti, Angela Raffaella Losito, Michele Bartoletti, Valerio Del Bono, Silvia Corcione, G. Maiuro, Sara Tedeschi, Luigi Celani, Chiara Simona Cardellino, Teresa Spanu, Anna Marchese, Simone Ambretti, Roberto Cauda, Claudio Viscoli, Pierluigi Viale, on behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante‐Mangoni, Giuseppe Signoriello, Roberto Andini, A. Mattei, Maria De Cristoforo, Patrizia Murino, Matteo Bassetti, P Malacarne, Nicola Petrosillo, Nicola Galdieri, Paola Elvira Mocavero, Antonio Corcione, Claudio Viscoli, Raffaele Zarrilli, Ciro Gallo, Riccardo Utili